Clinical behaviour and outcome in pediatric glioblastoma: current scenario
Radiation Oncology Journal
;
: 72-77, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-895561
ABSTRACT
Pediatric glioblastoma (pGBM) is a rare entity accounting for only approximately 3% of all childhood brain tumors. Treatment guidelines for pGBM have been extrapolated from those in adult glioblastoma. Rarity of pGBM and underrepresentation of pediatric population in major studies precludes from defining the ideal treatment protocol for these patients. Maximum safe resection is performed in most of the cases followed by postoperative radiotherapy in children over 3 years of age. Benefit of temozolomide is unclear in these patients. Here, we present the clinicopathological details and outcome of six pGBM patients treated at our institute in 2018–2019.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
Idioma:
Inglés
Revista:
Radiation Oncology Journal
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS